Paeds · nephrology-urology-fluids-and-electrolytes
Kidney transplantation in children
Also known as Paediatric renal transplantation · Kidney transplant in children · Preemptive kidney transplant · Living donor kidney transplant
Fellowship guide to paediatric kidney transplantation: why a transplanted kidney is the treatment of choice over lifelong dialysis for a child with end-stage kidney disease; the living-donor versus deceased-donor and preemptive versus dialysis-first classifications that predict graft survival; the standard tacrolimus, mycophenolate and steroid maintenance regimen with therapeutic drug monitoring; the distinction between T-cell-mediated and antibody-mediated rejection and how each is treated; and the leading threats to long-term graft survival including non-adherence in adolescence and chronic antibody-mediated rejection.
On this page
Study tools
Your progress
Saved on this device.
Practise this topic
Target exams
Red flags
- Sudden oliguria and a swollen tender graft in the early post-operative period suggesting renal vessel thrombosis and imminent graft loss
- A rising creatinine in a transplanted child that may represent acute rejection, calcineurin inhibitor toxicity, obstruction or recurrence of original disease
- Early and massive proteinuria within hours of transplant suggesting recurrence of focal segmental glomerulosclerosis requiring urgent plasmapheresis
- Fever with a rising EBV viral load in an EBV-mismatched recipient suggesting evolving post-transplant lymphoproliferative disorder
- Rising creatinine with a high BK virus load suggesting BK nephropathy that mimics acute rejection
- An adolescent with erratic tacrolimus levels, missed clinic visits and graft dysfunction suggesting non-adherence as the cause of late rejection
- Severe hypovolaemia or hypotension in the early post-operative period precipitating delayed graft function and acute tubular necrosis
Life stages
Care settings
Clinical exam formats
Board mappings
- Recognises kidney transplantation as the treatment of choice for end-stage kidney disease in children and outlines donor source and timing classification
- Identifies the standard maintenance immunosuppression regimen and the need for lifelong follow-up
- Refers children with advanced chronic kidney disease to a transplant centre early and considers preemptive living-donor transplant
- Justifies the choice of induction and maintenance immunosuppression based on immunological risk and explains calcineurin inhibitor pharmacology and monitoring
- Distinguishes T-cell-mediated from antibody-mediated rejection and manages each appropriately, including recurrent disease and BK nephropathy
- Leads adolescent transition, manages non-adherence, and addresses the long-term complications of chronic immunosuppression including PTLD and post-transplant diabetes
- Classification of kidney transplantation by donor source and timing, preemptive versus dialysis-first
- Standard maintenance immunosuppression and the role of therapeutic drug monitoring
- Causes of graft dysfunction in a transplanted child and the principles of investigation
- Assesses and investigates a rising creatinine in a paediatric kidney transplant recipient
- Counsels a family on living-donor versus deceased-donor transplant and the benefits of preemptive transplantation
- Manages an adolescent transplant recipient with suspected non-adherence and graft dysfunction
- Level 1: Recognises kidney transplant as the preferred treatment for end-stage kidney disease in children
- Level 2: Outlines immunosuppression principles and the common early complications of transplantation
- Level 3: Manages graft dysfunction, rejection and long-term complications, and leads transition to adult care
- Indications for kidney transplantation in children and the leading causes of paediatric end-stage kidney disease
- Classification into living versus deceased donor and preemptive versus dialysis-first
- The standard immunosuppression regimen and the timeline of post-transplant infections including PTLD
- Assessment and investigation of graft dysfunction in a child after kidney transplant
- Interpretation of a creatinine rise with tacrolimus trough and donor-specific antibody results
- Structured explanation of induction, maintenance immunosuppression and rejection treatment
- Recognition of kidney transplantation as optimal renal replacement therapy for children with end-stage kidney disease
- Principles of induction and maintenance immunosuppression including tacrolimus therapeutic monitoring
- Diagnosis and management of acute rejection, infection and post-transplant lymphoproliferative disorder
- Recognises the indications for and benefits of paediatric kidney transplantation
- Initiates appropriate workup and referral for transplant including vaccination and tissue typing
- Identifies graft dysfunction and the common complications of chronic immunosuppression
- Canadian approach to paediatric kidney transplant candidate selection and donor source
- Immunosuppression protocols and the management of rejection and opportunistic infection
- Long-term surveillance, growth, transition and graft-loss prevention strategies
Overview & Definition
A child whose kidneys have failed has end-stage kidney disease, and the question becomes how to replace what the kidneys did. There are two ways: dialysis, which filters the blood by machine or through the abdomen, or a kidney transplant, in which a healthy kidney from a donor is surgically placed in the child's lower abdomen. A transplanted kidney is the treatment of choice for almost every child with end-stage kidney disease, because it does what dialysis cannot: it works continuously, frees the child from the machine, restores near-normal growth and development, and improves long-term survival. [1]
The new kidney does not replace the old ones. The child's own failed kidneys usually stay in place, and the donor kidney is placed in the iliac fossa, the lower abdomen, where its blood vessels are joined to the large pelvic vessels and its ureter is connected to the bladder. The operation is the easy part. The hard part, which dominates everything afterwards, is that the child's immune system sees the donor kidney as foreign and will attack and destroy it unless the child takes immunosuppressant medicines every single day for life. This balance, between protecting the graft and avoiding the infections and cancers that immunosuppression permits, is what paediatric transplant medicine is about. [2]
References12ShowHide
- [1]Roach JP, Bock ME, Goebel J Pediatric kidney transplantation. Semin Pediatr Surg, 2017.PMID 28964479
- [2]Holmberg C, Jalanko H Long-term effects of paediatric kidney transplantation. Nat Rev Nephrol, 2016.PMID 26656457
- [3]Winterberg PD, Garro R Long-Term Outcomes of Kidney Transplantation in Children. Pediatr Clin North Am, 2019.PMID 30454748
- [4]Kidney Disease: Improving Global Outcomes (KDIGO) Transplant Work Group KDIGO clinical practice guideline for the care of kidney transplant recipients. Am J Transplant, 2009.PMID 19845597
- [5]Chadban SJ, Barraclough KA, Campbell SB, et al KHA-CARI guideline: KHA-CARI adaptation of the KDIGO Clinical Practice Guideline for the Care of Kidney Transplant Recipients. Nephrology (Carlton), 2012.PMID 22212251
- [6]Kizilbash SJ, Jensen CJ, Kouri AM, et al Steroid avoidance/withdrawal and maintenance immunosuppression in pediatric kidney transplantation. Pediatr Transplant, 2022.PMID 34786800
- [7]Balani SS, Jensen CJ, Kouri AM, et al Induction and maintenance immunosuppression in pediatric kidney transplantation-Advances and controversies. Pediatr Transplant, 2021.PMID 34216190
- [8]Weber LT Therapeutic drug monitoring in pediatric renal transplantation. Pediatr Nephrol, 2015.PMID 24763544
- [9]Ng YW, Singh M, Sarwal MM Antibody-mediated rejection in pediatric kidney transplantation: pathophysiology, diagnosis, and management. Drugs, 2015.PMID 25813498
- [10]Ashoor IF, Engen RM, Puliyanda D, et al Antibody-mediated rejection in pediatric kidney transplant recipients: A report from the Pediatric Nephrology Research Consortium. Pediatr Transplant, 2024.PMID 38602171
- [11]Scaggs Huang FA, Danziger-Isakov L Infectious disease risks in pediatric renal transplantation. Pediatr Nephrol, 2019.PMID 29626241
- [12]Holmberg C Nonadherence after pediatric renal transplantation: detection and treatment. Curr Opin Pediatr, 2019.PMID 30672821